Ingevity Corporation

Fundamentals5.0
Price Action4.0
News Sentiment0.0
AI Rating
5.0

Key Drivers

  • Margin rebound
  • Leverage strain
  • Cash volatility

AI
AI Summary

5.0

NGVT is shifting from a broad specialty-chemicals story to a leaner, higher-margin portfolio-reset play, but the investment still hinges on proving that the improved Q1 margins can translate into durable free cash flow and lower leverage before the market rerates the stock.

Turnaround‍
CashFlow‍
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Margin rebound
  • Leverage strain
  • Cash volatility

NGVT posted a strong Q1 2026 turnaround with sharply higher margins and profitability, but the outlook is still constrained by heavy leverage, thin equity, and inconsistent cash flow.

MarginRebound
LeverageRisk

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Support test
  • Resistance cap

NGVT remains in a short-term downtrend over the last month, with lower highs and repeated failures in the $71-$76 resistance band, though it is nearing $67.5-$68 support and could bounce if that floor holds.

downtrend
oversold
Support Level: $67.5 to $68.0
Resistance Level: $71.0 to $76.0

Brief rally to $77.87 was quickly reversed, reinforcing weak momentum

Sentiment & News

0.0

Key News Insights:

  • Pricing discipline
  • Margin strength
  • Share buybacks

Ingevity delivered a strong first quarter by beating estimates on pricing gains and FX support, reaffirming its full-year outlook despite weakness in Road Markings and lower utilization.

earnings
outlook

The quarter is likely supportive for the stock, as better-than-expected results and steady capital returns offset ongoing end-market pressure